We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $7.21B
1-Year Est. Return 20.54%
This Fund
S&P 500
This Quarter Est. Return
-10.41%
1 Year Est. Return
+20.54%
3 Year Est. Return
+87.88%
5 Year Est. Return
+88.87%
10 Year Est. Return
+277.95%
AUM
$903M
AUM Growth
-$17.9M
Cap. Flow
+$36.3M
Cap. Flow %
4.02%
Top 10 Hldgs %
93.34%
Holding
139
New
30
Increased
24
Reduced
13
Closed
62

Top Buys

Rank Stock Value
1
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
+$27.4M
2
GILD icon
Gilead Sciences
GILD
+$5.66M
3
SPTI icon
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
+$3.97M
4
PFE icon
Pfizer
PFE
+$3.04M
5
NVO
Novo Nordisk
NVO
+$2.83M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.2M
2
BND icon
Vanguard Total Bond Market
BND
+$8.62M
3
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
+$5.39M
4
BLUE
bluebird bio
BLUE
+$3.78M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.64M

Sector Composition

Rank Sector Weight
1 Healthcare 1.33%
2 Financials 0.61%
3 Industrials 0.31%
4 Technology 0.22%
5 Energy 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RQI icon
101
Cohen & Steers Quality Income Realty Fund
RQI
$1.71B
– –
-14,700
Closed -$157K
SJNK icon
102
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
– –
-99,865
Closed -$2.89M
SLV icon
103
iShares Silver Trust
SLV
$28.1B
– –
-234,040
Closed -$3.33M
SPY icon
104
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
– –
-25,100
Closed -$5.17M
SPY icon
105
State Street SPDR S&P 500 ETF Trust
SPY
$778B
– –
-17,701
Closed -$3.64M
SPY icon
106
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
– –
-25,100
Closed -$5.17M
TMV icon
107
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$180M
– –
-12,690
Closed -$1.08M
TXN icon
108
Texas Instruments
TXN
$255B
– –
-19,900
Closed -$1.02M
VGSH icon
109
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
– –
-7,713
Closed -$471K
VRTX icon
110
Vertex Pharmaceuticals
VRTX
$121B
– –
-83,000
Closed -$10.2M
ZTS icon
111
CALL
Zoetis
ZTS
$31.6B
– –
-9,900
Closed -$477K
RVNC
112
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-34,000
Closed -$1.09M
PRTK
113
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-11,512
Closed -$297K
ADMS
114
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-21,800
Closed -$572K
MDCO
115
CALL
DELISTED
Medicines Co
MDCO
– –
-38,400
Closed -$1.1M
CTRL
116
CALL
DELISTED
Control4 Corporation
CTRL
– –
-16,000
Closed -$142K
HZNP
117
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-43,500
Closed -$1.51M
AET
118
CALL
DELISTED
Aetna Inc
AET
– –
-6,800
Closed -$867K
KLXI
119
DELISTED
KLX Inc.
KLXI
– –
-11,068
Closed -$412K
CAA
120
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
– –
-14,720
Closed -$656K
POT
121
CALL
DELISTED
Potash Corp Of Saskatchewan
POT
– –
-16,500
Closed -$511K
ELOS
122
DELISTED
Syneron Medical Ltd
ELOS
– –
-85,000
Closed -$903K
ZLTQ
123
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-30,000
Closed -$884K
CSC
124
PUT
DELISTED
Computer Sciences
CSC
– –
-18,747
Closed -$519K
CYNO
125
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-6,000
Closed -$231K
2 3 4
5
6

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

DRW Securities's Q3 2015 Portfolio in Review

As of Q3 2015, DRW Securities held 139 positions worth $903M, down 1.9% from $921M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

DRW Securities deployed $36.3M of net new capital in Q3 2015, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Gilead Sciences: 51,000 shares worth $5.01M.

By sector, the portfolio is most concentrated in Healthcare at 1.3% of assets, down from 2.3% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $8.62M trimmed.

  • DRW Securities's largest Q3 2015 buy was Gilead Sciences: 51,000 shares worth $5.01M.
  • DRW Securities added most to VelocityShares Daily Inverse VIX Short Term ETN in Q3 2015, an estimated $27.4M increase.
  • DRW Securities's biggest Q3 2015 reduction was Vanguard Total Bond Market, cutting an estimated $8.62M.
  • DRW Securities fully exited Vertex Pharmaceuticals in Q3 2015, selling an estimated $10.2M.
  • DRW Securities's ten largest holdings make up 93% of its $903M portfolio in Q3 2015.
  • DRW Securities opened 30 new positions and closed 62 in Q3 2015.
  • DRW Securities's portfolio value fell 1.9% quarter-over-quarter to $903M.

Based on DRW Securities's 13F filing for Q3 2015, filed 16 Nov 2015.